Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


6 Items
Title  Creator  Group name  Publishing year 
Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-? activity and CD8+ T-cell infiltration in breast cancer Honda et al. EquipeJC 2024
Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma Chiavarina et al. EquipeJC 2022-03
Metastatic colorectal cancer cells maintain the TGF? program and use TGFBI to fuel angiogenesis Chiavarina et al. EquipeVC 2021
Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases Blomme et al. EquipeAT Mar 2018
Innovative methodology for the identification of soluble biomarkers in fresh tissues Costanza et al. EquipeAT Feb 13, 2018
High stromal transforming growth factor ?-induced expression is a novel marker of progression and poor prognosis in gastric cancer Suzuki et al. EquipeAT Nov 2018
6 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés